IL2 and B-cell non-Hodgkin lymphoma: Phase I/II studies, conducted on patients with B cell lymphoma, showed lymphocyte expansion [81], and partial responses were observed in five out of 13 patients, while three out of 13 patients exhibited complete responses [80] when treated with DI-Leu16-IL-2.